Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - dutasteridum, tamsulosinum - capsule - dutasteridum 0.5 mg, tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, dutasterid-weichkapsel innerhalb der hartkapsel: propylenglycoli dicaprylocapras 299.46 mg corresp. propylenglycolum 112.8 mg, e 321, gelatina, e 171, glycerolum, triglycerida media, lecithinum ex soja q.s., tamsulosin-pellets in hartkapsel: cellulosum microcristallinum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1 cum polysorbatum 80 et natrii laurilsulfas corresp. natrium 0.09 mg, dibutylis sebacas, silica colloidalis hydrica, calcii stearas, kapselhülle: e 172 (nigrum), e 172 (rubrum), e 171, e 172 (flavum), gelatina, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. - iperplasia prostatica benigna - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - dutasteridum, tamsulosinum - capsule - dutasteridum 0.5 mg, tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, propylenglycoli monooctanoas corresp. propylenglycolum 112.65 mg, e 321, gelatina, glycerolum, e 171, acidi methacrylici et ethylis acrylatis polymerisatum 1:1 cum polysorbatum 80 et natrii laurilsulfas corresp. natrium 0.09 mg, cellulosum microcristallinum, dibutylis sebacas, silica colloidalis hydrica, calcii stearas, kapselhülle: gelatina, e 171, e 172 (nigrum), e 172 (rubrum), e 172 (flavum), drucktinte: propylenglycolum, lacca, e 172 (nigrum), ammoniae solutio concentrata, kalii hydroxidum, pro capsula. - iperplasia prostatica benigna - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mylan pharma gmbh - dutasteridum, tamsulosinum - capsule rigide - dutasteridum 0.5 mg, tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, dutasterid-weichkapsel innerhalb der hartkapsel: propylenglycoli dicaprylocapras corresp. propylenglycolum 112.65 mg, e 321, gelatina, glycerolum, e 171, triglycerida media, lecithinum ex soja q.s., tamsulosin-pellets in hartkapsel: acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum cum polysorbatum 80 et natrii laurilsulfas corresp. natrium 0.026 mg, cellulosum microcristallinum, dibutylis sebacas, silica colloidalis hydrica, calcii stearas, kapselhülle: e 172 (nigrum), e 172 (rubrum), e 171, e 172 (flavum), gelatina, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. - iperplasia prostatica benigna - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - dutasteridum, tamsulosini hydrochloridum - capsule - dutasteridum 0.5 mg, tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, dutasterid-weichkapsel innerhalb der hartkapsel: glyceroli monocaprylocapras, e 321, gelatina, glycerolum 64.2 mg, aqua purificata, e 171, e 172 (flavum), triglycerida media, lecithinum ex soja, tamsulosin-pellets in hartkapsel: cellulosum microcristallinum, magnesii stearas, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii hydroxidum corresp. natrium 0.05 mg, triacetinum, e 171, talcum, kapselhülle: hypromellosum, kalii chloridum, carrageenanum, e 171, e 110 0.06 mg, e 172 (rubrum), aqua purificata, pro capsula. - iperplasia prostatica benigna - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

xiromed sa - dutasteridum, tamsulosini hydrochloridum - capsule rigide - dutasteridum 0.5 mg, tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, dutasterid-weichkapsel innerhalb der hartkapsel: propylenglycoli monooctanoas corresp. propylenglycolum 112.65 mg, e 321, gelatina, e 171, glycerolum, triglycerida media, lecithinum ex soja, tamsulosin-pellets in hartkapsel: acidi methacrylici et ethylis acrylatis polymerisatum 1:1 cum polysorbatum 80 et natrii laurilsulfas corresp. natrium 0.09 mg, cellulosum microcristallinum, dibutylis sebacas, silica colloidalis hydrica, calcii stearas, kapselhülle: e 172 (nigrum), e 172 (rubrum), e 171, e 172 (flavum), gelatina, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. - iperplasia prostatica benigna - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

xiromed sa - dutasteridum - capsule molli - dutasteridum 0.5 mg, propylenglycoli monooctanoas 299.46 mg corresp. propylenglycolum 112.65 mg, e 321, gelatina, glycerolum, e 171, triglycerida media, lecithinum ex soja, pro capsula. - iperplasia prostatica benigna - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

glaxosmithkline ag - dutasteridum, tamsulosini hydrochloridum - capsule - dutasteridum 0.5 mg, tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, dutasterid-weichkapsel innerhalb der hartkapsel: glyceroli mono/dioctanoas/decanoas, e 321, gelatina, glycerolum, e 171, e 172, aqua purificata, triglycerida media, lecithinum ex soja, tamsulosin-pellets in hartkapsel: cellulosum microcristallinum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum cum polysorbatum 80 et natrii laurilsulfas, talcum, triethylis citras, aqua purificata, kapselhülle: carrageenanum, kalii chloridum, aqua purificata, hypromellosum, cera carnauba, maydis amylum, e 110 0.04-0.08 mg, e 171, e 172, drucktinte: lacca, propylenglycolum, e 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 245 µg. - iperplasia prostatica benigna - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - dutasteridum, tamsulosini hydrochloridum - capsule - dutasteridum 0.5 mg, tamsulosini hydrochloridum 0,4 mg corrisp. tamsulosinum 0.367 mg, antiox.: e 321, excipiens per la capsula. - iperplasia prostatica benigna - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - dutasteridum, tamsulosini hydrochloridum - capsule - dutasteridum 0.5 mg, tamsulosini hydrochloridum 0,4 mg corrisp. tamsulosinum 0.367 mg, antiox.: e 321, excipiens per la capsula. - iperplasia prostatica benigna - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

glaxosmithkline ag - dutasteridum - weichgelatinekapseln - dutasteridum 0.5 mg, antiox.: e 321, excipiens per la capsula. - iperplasia prostatica benigna - synthetika